oxlumo(lumasiran)Medication DetailsAlnylam Pharmaceuticals, Inc.Usage: OXLUMO is indicated for the treatment of primary hyperoxaluria type 1 (PH1) to reduce urinary and plasma oxalate levels in both pediatric and adult patients.Medication Details